Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
7776
Direxion Daily Transportation Bull 3X ETF
TPOR
$16M
| $97 | ﹤0.01% |
2
+1
| +100% | +$37 |
2023 Q4
10 quarters
|
|
7777
AB Ultra Short Income ETF
YEAR
$1.57B
| $97 | ﹤0.01% |
1
-103
| -99% | -$5.18K |
2026 Q1
1 quarter
|
|
|
NVTX
7778
Tradr 2X Long NVTS Daily ETF
NVTX
$34.4M
| $97 | ﹤0.01% |
+2
| New | +$153 |
2026 Q2
0 quarters
|
|
7779
Simplify US Equity PLUS Convexity ETF
SPYC
$83.7M
| $96 | ﹤0.01% |
2
+1
| +100% | +$44 |
2021 Q1
21 quarters
|
|
|
QDVO
7780
Amplify CWP Growth & Income ETF
QDVO
$788M
| $96 | ﹤0.01% |
3
+1
| +50% | +$30 |
2025 Q3
3 quarters
|
|
7781
Acquirers Small and Micro Deep Value ETF
DEEP
$27.2M
| $95 | ﹤0.01% |
2
+1
| +100% | +$40 |
2020 Q4
22 quarters
|
|
7782
ProShares Ultra High Yield
UJB
$5.94M
| $95 | ﹤0.01% |
1
-1
| -50% | -$78 |
2024 Q4
6 quarters
|
|
7783
Altrius Global Dividend ETF
DIVD
$23.6M
| $93 | ﹤0.01% |
2
+1
| +100% | +$42 |
2024 Q1
9 quarters
|
|
|
HDRN
7784
Hadron Energy
HDRN
$76.5M
| $93 | ﹤0.01% |
46
-128
| -74% | -$809 |
2025 Q4
2 quarters
|
|
|
JATT
7785
JATT II Acquisition Corp
JATT
$82.7M
| $91 | ﹤0.01% |
+8
| New | +$85 |
2026 Q2
0 quarters
|
|
7786
iShares ESG Advanced High Yield Corporate Bond ETF
HYXF
$189M
| $89 | ﹤0.01% |
+1
| New | +$47 |
2026 Q2
0 quarters
|
|
7787
ProShares Merger ETF
MRGR
$15.9M
| $89 | ﹤0.01% |
1
-1
| -50% | -$45 |
2025 Q1
5 quarters
|
|
7788
ProShares Ultra Health Care
RXL
$97.4M
| $89 | ﹤0.01% |
1
-1
| -50% | -$47 |
2025 Q4
2 quarters
|
|
7789
TCW Transform Supply Chain ETF
SUPP
$12M
| $89 | ﹤0.01% |
1
| – | – |
2023 Q4
10 quarters
|
|
|
ADGM
7790
Adagio Medical Holdings
ADGM
$3.53M
| $89 | ﹤0.01% |
137
| – | – |
2025 Q4
2 quarters
|
|
7791
ProShares MSCI Transformational Changes ETF
ANEW
$8.2M
| $88 | ﹤0.01% |
1
| – | – |
2023 Q3
11 quarters
|
|
7792
Invesco Investment Grade Defensive ETF
IIGD
$26.3M
| $87 | ﹤0.01% |
3
-676
| -100% | -$16.6K |
2024 Q2
8 quarters
|
|
7793
Alger 35 ETF
ATFV
$495M
| $86 | ﹤0.01% |
2
+1
| +100% | +$38 |
2024 Q4
6 quarters
|
|
7794
Simplify US Equity Income ETF
SPUC
$259M
| $85 | ﹤0.01% |
1
| – | – |
2026 Q1
1 quarter
|
|
|
MAGY
7795
Roundhill Magnificent Seven Covered Call ETF
MAGY
$105M
| $85 | ﹤0.01% |
2
+1
| +100% | +$45 |
2025 Q3
3 quarters
|
|
7796
Mustang Bio
MBIO
$3.03M
| $83 | ﹤0.01% |
118
| – | – |
2018 Q1
33 quarters
|
|
7797
Direxion Daily Consumer Discretionary Bull 3X ETF
WANT
$18.1M
| $83 | ﹤0.01% |
1
| – | – |
2020 Q3
23 quarters
|
|
7798
Inspire Growth ETF
GLRY
$164M
| $82 | ﹤0.01% |
1
-7
| -88% | -$288 |
2026 Q1
1 quarter
|
|
7799
Intensity Therapeutics
INTS
$11.9M
| $82 | ﹤0.01% |
20
| – | – |
2024 Q2
8 quarters
|
|
7800
ProShares Ultra MSCI Brazil Capped
UBR
$4.08M
| $82 | ﹤0.01% |
2
| – | – |
2024 Q1
9 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.